• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
[Efficacy of recombinant human coagulation factor Ⅶ and immunosuppressive agent in patients with acute intestinal graft versus host disease complicated with bleeding after allogeneic hematopoietic stem cell transplantation].重组人凝血因子Ⅶ与免疫抑制剂治疗异基因造血干细胞移植术后合并出血的急性肠道移植物抗宿主病患者的疗效观察
Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):156-158. doi: 10.3760/cma.j.issn.0253-2727.2018.02.016.
2
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.与一线使用环孢素和/或抗胸腺细胞或抗淋巴细胞球蛋白治疗获得性重型再生障碍性贫血相比，HLA匹配的同胞供者进行一线异基因造血干细胞移植的情况。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2.
3
Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.异基因干细胞移植患者放疗后发生移植物抗宿主病：两例报告
J Med Case Rep. 2016 Jul 28;10:209. doi: 10.1186/s13256-016-0999-z.
4
Allogeneic Hematopoietic Stem Cell Transplantation Mobilized With Pegylated Granulocyte Colony-Stimulating Factor Ameliorates Severe Acute Graft-Versus-Host Disease Through Enrichment of Monocytic Myeloid-Derived Suppressor Cells in the Graft: A Real World Experience.聚乙二醇化粒细胞集落刺激因子动员的异基因造血干细胞移植通过在移植物中富集单核细胞来源的髓系抑制细胞改善严重急性移植物抗宿主病：真实世界经验。
Front Immunol. 2021 Apr 12;12:621935. doi: 10.3389/fimmu.2021.621935. eCollection 2021.
5
Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases.自体造血干细胞移植后移植物抗宿主病的胃肠道病理学：17 例临床病理研究。
Mod Pathol. 2011 Jan;24(1):117-25. doi: 10.1038/modpathol.2010.163. Epub 2010 Oct 15.
6
[Clinical efficacy of recombinant activated factor Ⅶ a for 16 hematonosis with moderate or severe bleeding].重组活化因子Ⅶa治疗16例中重度出血血液病的临床疗效
Zhonghua Xue Ye Xue Za Zhi. 2017 Mar 14;38(3):216-221. doi: 10.3760/cma.j.issn.0253-2727.2017.03.008.
7
Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.非清髓性 HLA 匹配同胞供体异基因造血干细胞移植治疗严重镰状细胞表型。
JAMA. 2014 Jul 2;312(1):48-56. doi: 10.1001/jama.2014.7192.
8
Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant.异基因造血干细胞移植中含利妥昔单抗预处理方案的移植物抗宿主病风险
J Oncol Pharm Pract. 2017 Jun;23(4):255-263. doi: 10.1177/1078155216637216. Epub 2016 Mar 11.
9
Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease.异基因造血细胞移植前血浆瓜氨酸水平低与严重胃肠道移植物抗宿主病的关系。
Clin Gastroenterol Hepatol. 2018 Jun;16(6):908-917.e2. doi: 10.1016/j.cgh.2017.12.024. Epub 2017 Dec 16.
10
Efficacy of Recombinant Human Soluble Thrombomodulin in Treating Disseminated Intravascular Coagulation Complicating Allogeneic Hematopoietic Stem Cell Transplantation.重组人可溶性血栓调节蛋白治疗异基因造血干细胞移植并发弥散性血管内凝血的疗效
Acta Haematol. 2018;140(2):121-127. doi: 10.1159/000492105. Epub 2018 Sep 18.

本文引用的文献

1
Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia.重组凝血因子VIIa在血小板减少的造血干细胞移植患者胃肠道出血难以控制时的应用。
Pak J Med Sci. 2015 Nov-Dec;31(6):1389-93. doi: 10.12669/pjms.316.8357.
2
Treatment of massive gastrointestinal bleeding occurred during autologous stem cell transplantation with recombinant activated factor VII and octreotide.重组活化凝血因子VII与奥曲肽治疗自体干细胞移植期间发生的大量胃肠道出血。
J Cancer Res Ther. 2015 Jul-Sep;11(3):667. doi: 10.4103/0973-1482.138106.
3
Successful control of massive gastrointestinal bleeding following umbilical cord blood transplantation (UCBT) by use of recombinant activated factor VII (rFVIIa) and octreotide infusion.通过使用重组活化因子VII（rFVIIa）和奥曲肽输注成功控制脐血移植（UCBT）后大量胃肠道出血。
Pediatr Hematol Oncol. 2010 Feb;27(1):24-30. doi: 10.3109/08880010903376988.
4
Hemorrhagic and thrombotic complications in bone marrow transplant recipients.骨髓移植受者的出血和血栓形成并发症
Thromb Res. 2007;120 Suppl 2:S92-8. doi: 10.1016/S0049-3848(07)70136-6.
5
Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation.
Biol Blood Marrow Transplant. 2007 May;13(5):622-3. doi: 10.1016/j.bbmt.2007.01.070.
6
The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review.重组活化凝血因子VII在治疗重症血液肿瘤出血中的潜在作用：一项系统综述
Bone Marrow Transplant. 2007 Jun;39(12):729-35. doi: 10.1038/sj.bmt.1705670. Epub 2007 Apr 9.
7
Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.使用重组人凝血因子VIIa后的血栓栓塞不良事件。
JAMA. 2006 Jan 18;295(3):293-8. doi: 10.1001/jama.295.3.293.
8
Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation.重组活化凝血因子VII治疗造血干细胞移植后的出血并发症
J Thromb Haemost. 2005 Sep;3(9):1935-44. doi: 10.1111/j.1538-7836.2005.01523.x.
9
Haemopoietic stem cell transplants: the impact of haemorrhagic complications.造血干细胞移植：出血并发症的影响
Blood Rev. 2003 Sep;17 Suppl 1:S6-10. doi: 10.1016/s0268-960x(03)90001-4.
10
Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.骨髓移植中的止血并发症：447例患者的回顾性分析
Transplantation. 2002 Nov 15;74(9):1303-9. doi: 10.1097/00007890-200211150-00018.

[Efficacy of recombinant human coagulation factor Ⅶ and immunosuppressive agent in patients with acute intestinal graft versus host disease complicated with bleeding after allogeneic hematopoietic stem cell transplantation].

作者信息

Chen X, Zhai W H, Ma Q L, Yao J F, Li G, Liang C, Jiang E L, Feng S Z, Han M Z

机构信息

Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):156-158. doi: 10.3760/cma.j.issn.0253-2727.2018.02.016.

DOI:10.3760/cma.j.issn.0253-2727.2018.02.016
PMID:29562453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7342562/
Abstract
摘要